SCHEMBL29856147

SCHEMBL29856147

CCc1c(C(=O)c2ccc(O)cc2)c2ncncc2n1C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.36
ALOX15 P16050 2/20 0.36
ALDH1A1 P00352 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
SLC22A12 Q96S37 5/20 0.34
EYA3 Q99504 2/20 0.34
MAPT P10636 3/20 0.34
HTT P42858 2/20 0.34
ESR1 P03372 2/20 0.34
ESR2 Q92731 2/20 0.34
PKM P14618 1/20 0.34
HPGD P15428 1/20 0.34
ATM Q13315 1/20 0.33
HDAC6 Q9UBN7 2/20 0.33
CYP2C9 P11712 1/20 0.33
CYP19A1 P11511 1/20 0.33
DEGS1 O15121 1/20 0.32
AKR1B1 P15121 1/20 0.32
HSD17B3 P37058 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29856249 0.84 SRD5A2 (0.47) ALDH1A1MAPTHTTCYP19A1SMN1; SMN2
SCHEMBL29856162 0.82 SLC22A12 (0.37) LMNAALDH1A1SLC22A12EYA3MAPT
SCHEMBL29856273 0.81 COMT (0.40) LMNAALOX15ALDH1A1NPSR1SLC22A12
SCHEMBL29856237 0.80 MAPT (0.40) LMNAALOX15ALDH1A1NPSR1SLC22A12
SCHEMBL29856214 0.79 KDM5A (0.40) LMNASLC22A12EYA3MAPTHTT
SCHEMBL29856217 0.76 TUBB4A (0.41) LMNASLC22A12EYA3MAPTHTT
SCHEMBL29856224 0.75 LMNA (0.37) LMNAALOX15ALDH1A1NPSR1SLC22A12
SCHEMBL29856234 0.71 ALOX15 (0.40) LMNAALOX15ALDH1A1NPSR1SLC22A12
SCHEMBL29856238 0.68 SLC22A12 (0.43) SLC22A12EYA3HDAC6CYP2C9HSD17B3
SCHEMBL29856192 0.68 KDM5A (0.50) SLC22A12EYA3MAPTHTTHDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022169974-A1 INHIBITORS OF URAT1 AND PHARMACEUTICAL USES THEREOF NEXYS THERAPEUTICS, INC. (US) 2022-08-11 WO disclosed